Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Completed1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT02942173Phase 2/3Completed
CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT
Graft-versus-Host DiseaseGvHDLeukemia+3 more
StudychairStart date: 2016-10-01

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Fedaral Research Center for pediatric hematology, oncology and immunology

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Michael Maschan, PhD

Fedaral Research Center for pediatric hematology, oncology and immunology

Similar
1 trials

Shared therapeutic areas:

Graft vs Host DiseaseGVHDLeukemia+3 more

Worked with same sponsors:

Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Collaborated on 1 trial
Similarity Score64%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

LeukemiaLymphomaGraft vs Host Disease+1 more
Similarity Score20%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

LeukemiaLymphomaMyelodysplastic Syndromes
Similarity Score15%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Graft vs Host DiseaseLymphomaMyelodysplastic Syndromes
Similarity Score15%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic SyndromesLymphoma
Similarity Score15%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Myelodysplastic SyndromesGraft vs Host DiseaseLymphoma
Similarity Score15%

Steven R. Alberts, MD

Mayo Clinic

Related
14 trials

Shared therapeutic areas:

LeukemiaLymphomaMyelodysplastic Syndromes
Similarity Score15%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Graft vs Host DiseaseLeukemiaLymphoma
Similarity Score15%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

LeukemiaLymphoma
Similarity Score10%

Gary Schiller, MD

University of California, Los Angeles

Related
3 trials

Shared therapeutic areas:

LeukemiaLymphoma
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02942173Phase 2/3StudyChair

CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT

Graft-versus-Host DiseaseGvHDLeukemia+3 more
Completed

All 1 trials loaded